GDUFA

Acronym of the week would be more accurate, but GDUFA will be used as a word so it might as well be defined as one.  With the passage of the Food and Drug Administration Safety and Innovation Act on July 9, 2012, GDUFA (‘Generic Drug User...
                          

Latest Posts

Tim Weinheimer's picture

The "New" Patient Journey: How Mobile is Transforming Healthcare

0 comments

Mobile is changing healthcare marketing and 213
communications in three major ways. First, it's transformed the creation of content and the way communicators determine what's relevant and to whom. Secondly, it's changed how communicators create and inhabit platforms —specifically to engage and converse with people and patients. Finally, mobile has shifted communicators’ views of what’s actually valuable to a patient long before the doctor actually take his or her temperature!

Patient engagement has gone from a triage to a “four-age”: Sixty percent of U.S. patients are using their smart device while waiting for an appointment and even during the doctor visit. The classic teachable moment has gone from a party of three with the doctor, patient and nurse to a party of four that now includes a mobile device. Clearly knowing and understanding your mobile patient’s profile is job one. Read full post »

Alison Rogove's picture

FDA Webinar on Social Media Draft Guidances: Still Seeking Long-Awaited Clarity

0 comments

212 Healthcare consumers, patients and professionals are relying more and more on digital and social media forums, and online resources for medical and health information. Healthcare knowledge sharing via social media is also a growing practice. As digital and social engagement on health continues to grow, so do questions on best practices for industry, such as pharmaceutical companies. On July 10th, the U.S. Food and Drug Administration (FDA) hosted a highly-anticipated webinar and public Q&A session to discuss its stance on the use of social media by the healthcare industry (slides available here). Specifically, the FDA addressed three draft guidance documents it has issued in recent months, all with one common goal – to help shed some light on how the industry can join this powerful conversation.

 

What were the key takeaways from the FDA’s session? Read full post »

Lee Duong's picture

Debunking Arthritis Myths – Recognizing National Arthritis Month

0 comments

Your family doctor recently told your young nephew he has juvenile arthritis. Your friend in her 20s is living with rheumatoid arthritis. They seem to be unlikely arthritis patients, and this comes as a surprise to you – don’t only older people get arthritis?

Arthritis is a medical term that we hear about often, but most characteristics about the disease that come to mind are simply misconceptions. Arthritis affects more than 50 million Americans – one in five adults has the disease where common symptoms include pain, aching, stiffness and swelling in or around the joints. Arthritis can affect people of various backgrounds and its severity can be greater than most may think.  Read full post »

In: Consumer Health  /   filed under: national arthritis month
Michelle Mahony's picture

How Change in Healthcare Impacts Providers and Healthcare Organizations

2 comments

Healthcare in the United States and around the globe is going through unprecedented changes that will fundamentally transform how care is delivered to patients. All of this is occurring against a backdrop of:

205

While the future of healthcare is still in flux, all major insurers, hospitals, academic medical institutions and industry participants acknowledge that the current model is not sustainable going forward.Read full post »

Shawn Ghuman's picture

Antibiotic Resistance in Bacteria is Another Crisis Worth Preventing

0 comments

MRSA Antibiotic Resistance in the United States

Although a majority of MRSA cases are still limited to hospitals and intensive care units, it has become apparent that MRSA is expanding out into
communities and has become a larger public 
health crisis.

204